Is JNJ a good investment in 2026?

Johnson & Johnson trades at a P/E ratio of 26.5, with medium volatility (17.5% annualized). The stock is in a consolidation phase.

What is the risk level of JNJ?

Based on 30-day volatility of 17.5%, JNJ has MEDIUM risk. Beta of 0.26 indicates lower sensitivity to market movements than average.

Johnson & Johnson (JNJ) Stock Analysis & Price Outlook

Q: Does JNJ pay dividends?

Yes, Johnson & Johnson has a dividend yield of 2.32%.

Key Metrics

MARKET CAP

$549.57B

P/E RATIO

26.5

BETA

0.26

Less volatile

DIV YIELD

2.32%

52W HIGH

$251.71

52W LOW

$149.04

VOLATILITY

17.5%

30d annualized

Price Performance

30-DAY PRICE CHART

$227.79 → $228.30+0.22%

30 days agoToday

1-YEAR PERFORMANCE

$155.21 → $228.30+47.1%

JNJ | 52-week chartLast updated: 5/29/2026

Healthcare Sector Context

Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.

METRIC	JNJ	SECTOR AVG	VS SECTOR
P/E Ratio	26.5x	22.0x	↑ 20%
Beta	0.26	0.85	Less volatile
Div Yield	2.32%	1.50%	Above avg
30d Volatility	17.5%	22%	Lower risk

TOP HEALTHCARE PEERS

UNH PFPFE ABABBV

Competitors Analysis

Compare JNJ's key metrics against its main healthcare sector competitors.

COMPANY	PRICE	MARKET CAP	SECTOR
JNJ(You are here)	$228.30	$549.57B	Healthcare	—
UNH	$378.83	$344.03B	Healthcare	VIEW →
PFPFE	$26.09	$148.73B	Healthcare	VIEW →
ABABBV	$218.03	$385.21B	Healthcare	VIEW →

Click on a competitor to view their full analysis

Technical Analysis

Johnson & Johnson is currently trading at $228.30, which is 9.3% below its 52-week high. With a beta of 0.26, the stock shows lower sensitivity to market movements.

RSI (14)NEUTRAL

30-DAY TRENDNEUTRAL

VOLUME1.8M(Below avg)

Frequently Asked Questions

Is JNJ a good buy right now?

Johnson & Johnson trades at 26.5x earnings. This is near market average. Current risk level is Medium based on 17.5% volatility.

Does JNJ pay dividends?

Yes, Johnson & Johnson offers a dividend yield of 2.32%. This translates to approximately $5.30 per share annually.

How volatile is JNJ?

With 30-day annualized volatility of 17.5% and beta of 0.26,JNJ is classified as Medium risk. The stock tends to be more stable than the market average.

Related Assets

LLLLYANALYZE →

Eli Lilly and Company

Track JNJ Live

Add Johnson & Johnson to your Portfolio Terminal for real-time alerts and risk updates.

OPEN TERMINAL IMPORT BROKER FILE

Last updated: 5/29/2026, 2:23:31 PM